Tropical Medicine
SR | Interventions to improve sanitation for preventing diarrhea
27 Jan, 2023 | 12:15h | UTCInterventions to improve sanitation for preventing diarrhoea – Cochrane Library
Summary: Interventions to improve sanitation for preventing diarrhoea – Cochrane Library
Commentary on Twitter
New @Cochrane_IDG review: Interventions to improve #sanitation for preventing #diarrhoea https://t.co/pMvEzGNJ7q
⭐️sanitation interventions are effective, for young children and all age populations
⭐️effectiveness varies by intervention type & setting
⭐️further research needed— Cochrane_IDG (@Cochrane_IDG) January 25, 2023
WHO Report | Cholera global situation
26 Jan, 2023 | 12:56h | UTCCholera – Global situation – World Health Organization
Commentary: WHO Report: Cholera Resurgent in 2022 After Years of Decline – JAMA
Rapid review on monkeypox policies among the G20 nations: relevance to policy and practitioner
13 Jan, 2023 | 13:34h | UTC
Retrospective Study | Clinical features and management of individuals admitted to hospital with monkeypox
13 Jan, 2023 | 13:33h | UTC
Monkeypox (hMPXV infection): a practical review
11 Jan, 2023 | 14:25h | UTCMonkeypox (hMPXV infection): A practical review – American Journal of Medicine
WHO Interim Guidance | Surveillance, case investigation and contact tracing for mpox (monkeypox)
10 Jan, 2023 | 14:45h | UTC
RCTs | Vaccines for Zaire Ebola virus disease.
16 Dec, 2022 | 13:46h | UTCRandomized Trial of Vaccines for Zaire Ebola Virus Disease – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Ebola vaccine regimens safe, immunogenic in adults and children – NIH News Releases
Commentaries:
Ebola vaccine strategies show safety and immune response – CIDRAP
Commentary on Twitter
In two randomized trials of Ebola vaccines, safety and immune responses in adults and children were assessed for three regimens with two different vaccines. All three induced immune responses lasting at least 1 year. https://t.co/JUMN8Ieygv pic.twitter.com/NajlnA2B7y
— NEJM (@NEJM) December 14, 2022
SR | Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
14 Dec, 2022 | 14:51h | UTCTreatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins – Cochrane Library
WHO World malaria report 2022.
9 Dec, 2022 | 13:41h | UTCWorld malaria report 2022 – World Health Organization
News Release: Despite continued impact of COVID-19, malaria cases and deaths remained stable in 2021 – World Health Organization
Commentaries:
WHO: COVID disruption resulted in 63,000 more malaria deaths – Associated Press
WHO: Malaria cases, deaths remained stable in 2021, despite COVID – CIDRAP
M-A | Pregnancy outcomes after first-trimester treatment with artemisinin derivatives vs. non-artemisinin antimalarials.
6 Dec, 2022 | 14:02h | UTC
Commentary on Twitter (thread – click for more)
#Malaria in early pregnancy can have severe consequences.
Though an effective treatment, artemisinin-based combination therapies (ACTs) have not been recommended in the first trimester due to safety concerns.
A study presents updated evidence on safety: https://t.co/zBF7CAMRyY pic.twitter.com/2xRNvfTfx8
— The Lancet (@TheLancet) December 2, 2022
Monkeypox in pregnancy: virology, clinical presentation, and obstetric management.
6 Dec, 2022 | 13:58h | UTCRelated:
WHO renames “monkeypox” as “mpox” to help destigmatize the disease.
Study shows there is substantial monkeypox transmission before symptoms appear.
Monkeypox – New England Journal of Medicine
Monkeypox: disease epidemiology, host immunity and clinical interventions.
Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health
CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.
Update on the Monkeypox Outbreak – JAMA
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
Cohort Study | Preschool neurodevelopment in Zika virus-exposed children without congenital Zika syndrome.
5 Dec, 2022 | 00:09h | UTCNews Release: Zika-exposed children may display neurodevelopmental differences, study finds – Children’s National Hospital
Review | One health approach for the control of zoonotic diseases.
5 Dec, 2022 | 00:05h | UTCOne Health Approach for the Control of Zoonotic Diseases – Zoonoses
Commentary: Best practices and challenges in One Health approach to fight zoonotic diseases – News Medical
RCT | Single-dose Acoziborole is effective and safe for patients with sleeping sickness.
2 Dec, 2022 | 14:35h | UTCNews Release: New single-dose treatment for sleeping sickness could help eliminate transmission of the disease by 2030 – The Lancet
Commentary: Single dose of acoziborole 95% effective in treating sleeping sickness – CIDRAP
WHO renames “monkeypox” as “mpox” to help destigmatize the disease.
29 Nov, 2022 | 14:27h | UTCWHO recommends new name for monkeypox disease – World Health Organization
Commentaries:
WHO to phase out the name ‘monkeypox’ for ‘mpox’ – STAT
WHO renames monkeypox as mpox, citing racist stigma – NPR
The Future of Monkeypox – The Atlantic
Monkeypox given new name by global health experts – BBC
Monkeypox to be renamed mpox to avoid stigma, says WHO – The Guardian
Commentary on Twitter (thread – click for more)
Following consultations, WHO will begin using a new term for “#monkeypox” disease: '#mpox'.
Both names will be used simultaneously for one year while 'monkeypox' is phased out https://t.co/VT9DAdYrGY pic.twitter.com/Ae6zgkefPI— World Health Organization (WHO) (@WHO) November 28, 2022
Seminar | Monkeypox.
27 Nov, 2022 | 22:29h | UTCCommentaries:
Study shows there is substantial monkeypox transmission before symptoms appear.
Monkeypox – New England Journal of Medicine
Monkeypox: disease epidemiology, host immunity and clinical interventions.
Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health
CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.
Update on the Monkeypox Outbreak – JAMA
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
Commentary on Twitter
Seminar: Monkeypox
In light of the 2022 global outbreak, @oriolmitja and colleagues provide an overview of epidemiology, clinical presentation, treatment, prevention, and more.
📌 https://t.co/gB0fcokA8D pic.twitter.com/Db3ZsU4ykt
— The Lancet (@TheLancet) November 22, 2022
Global burden of Rabies in 204 countries and territories, from 1990 to 2019.
27 Nov, 2022 | 22:04h | UTC
Review | Climate change and vectorborne diseases.
24 Nov, 2022 | 13:31h | UTCClimate Change and Vectorborne Diseases – New England Journal of Medicine
Commentary on Twitter
Warming temperatures and changes in precipitation associated with climate change are affecting the occurrence of vectorborne diseases. Effective, equitable strategies are needed for vector control and disease management. https://t.co/o1yUTkjs93 pic.twitter.com/4Qn4RRXBcL
— NEJM (@NEJM) November 23, 2022
M-A | Global monkeypox case hospitalization rates.
21 Nov, 2022 | 14:36h | UTCRelated:
Monkeypox – New England Journal of Medicine
Monkeypox: disease epidemiology, host immunity and clinical interventions.
Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health
CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.
Update on the Monkeypox Outbreak – JAMA
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series.
21 Nov, 2022 | 14:35h | UTCCommentaries:
Study describes monkeypox in women; CDC warns of Tpoxx resistance – CIDRAP
Related:
Monkeypox – New England Journal of Medicine
Monkeypox: disease epidemiology, host immunity and clinical interventions.
Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health
CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.
Update on the Monkeypox Outbreak – JAMA
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
SR | Mosquito aquatic habitat modification and manipulation interventions to control malaria.
17 Nov, 2022 | 12:06h | UTC
RCT | Moxidectin and albendazole vs. ivermectin and albendazole in adolescents infected with Trichuris trichiura.
9 Nov, 2022 | 12:10h | UTCInvited Commentary: Alternative treatment strategies for trichuriasis – The Lancet Infectious Diseases
Perspective | Monkeypox — A sobering sentinel for pandemic preparedness and sexual health system capacity.
4 Nov, 2022 | 13:53h | UTCRelated:
Monkeypox – New England Journal of Medicine
Monkeypox: disease epidemiology, host immunity and clinical interventions.
Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health
CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.
Update on the Monkeypox Outbreak – JAMA
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
Commentary on Twitter
The monkeypox pandemic has highlighted lessons learned — and sometimes ignored — from Covid-19 and has illustrated the inadequacy of sexual health infrastructure and pandemic preparedness in the United States. https://t.co/jXuYoH9Wn2 pic.twitter.com/KcTqBuyEXi
— NEJM (@NEJM) November 2, 2022
Phase 2 RCT | A single injection of a monoclonal antibody was 88% effective for malaria prevention over 6 months.
2 Nov, 2022 | 14:30h | UTCSafety and Efficacy of a Monoclonal Antibody against Malaria in Mali – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Monoclonal antibody prevents malaria infection in African adults – National Institutes of Health
Commentary: Monoclonal antibody infusion 88% effective against malaria – CIDRAP
Related Study: Phase 1 Study | Low-dose subcutaneous or intravenous monoclonal antibody can prevent malaria in a human challenge model.
Commentary on Twitter
In this phase 2 trial in Mali, an antimalarial monoclonal antibody (CIS43LS) at the higher dose (40 mg per kilogram) was approximately 88% effective at preventing P. falciparum infection as compared with placebo. #TropMed22 https://t.co/UGeBHOPhKY pic.twitter.com/uFX7w3qV0G
— NEJM (@NEJM) November 1, 2022
CDC study shows healthcare workers have a low risk of infection after exposure to patients with monkeypox.
28 Oct, 2022 | 13:21h | UTCCommentaries:
Clinicians at Low Risk of Acquiring Monkeypox From Patients – JAMA
Low risk of monkeypox spread noted in health workers – CIDRAP
Risk of Monkeypox Transmission Low in Health Care Settings – HealthDay